---
title: "Kisqali (ribociclib), all indications: Storage and supply questions"
description: "Storage and supply questions on Kisqali (ribociclib) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Storage, How supplied, and Tablet. Questions: How should Kisqali be stored? What are the NDC numbers for Kisqali? What strength and appearance do Kisqali tablets have? 3 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/kisqali/storage-and-supply"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T01:54:55-05:00"
---

# Kisqali (ribociclib), all indications: Storage and supply questions

Manufacturer: Novartis Pharmaceuticals Corporation  
Prescribing information: [Kisqali](https://www.novartis.com/us-en/sites/novartis_us/files/kisqali.pdf)  
Indication pages: [HR-positive HER2-negative advanced or metastatic breast cancer](https://www.evicenter.com/medical-information/kisqali--hr-positive-her2-negative-advanced-or-metastatic-breast-cancer)

## Storage

<a id="kisqali-storage"></a>

### How should Kisqali be stored?

> “Store at room temperature at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F). 
> Store in the original blister package in order to protect from moisture.”

Source: [KISQALI: Prescribing information, page 31, captured 2026-11-13](https://www.novartis.com/us-en/sites/novartis_us/files/kisqali.pdf#page=31)

## How supplied

<a id="kisqali-ndc"></a>

### What are the NDC numbers for Kisqali?

> “Carton of 3 blister packs (63 tablets total) – each blister pack contains a 7-day supply of 21 tablets (200 mg per tablet)  
> (600 mg daily dose). 
>
>
>
>
>
>
>
>
>
> NDC 0078-0874-63 
> Carton of 3 blister packs (42 tablets total) – each blister pack contains a 7-day supply of 14 tablets (200 mg per tablet)  
> (400 mg daily dose). 
>
>
>
>
>
>
>
>
>
> NDC 0078-0867-42 
> Carton of 1 blister pack (21 tablets total) – each blister pack contains a 21-day supply of 21 tablets (200 mg per tablet)  
> (200 mg daily dose). 
>
>
>
>
>
>
>
>
>
> NDC 0078-0860-01”

Source: [KISQALI: Prescribing information, page 31, captured 2026-11-13](https://www.novartis.com/us-en/sites/novartis_us/files/kisqali.pdf#page=31)

## Tablet

<a id="kisqali-tablet"></a>

### What strength and appearance do Kisqali tablets have?

> “Tablet: 200 mg ribociclib (equivalent to 254.40 mg ribociclib succinate).  
> Film coated, light greyish violet, round, curved with beveled edges, debossed with “RIC” on one side and “NVR” on the 
> other side.”

Source: [KISQALI: Prescribing information, page 7, captured 2026-11-13](https://www.novartis.com/us-en/sites/novartis_us/files/kisqali.pdf#page=7)

## Related pages
- [Medical information: Kisqali (ribociclib): All indications](https://www.evicenter.com/medical-information/kisqali)
- [Indication](https://www.evicenter.com/medical-information/kisqali/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/kisqali/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/kisqali/safety)
- [Specific populations](https://www.evicenter.com/medical-information/kisqali/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/kisqali/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/kisqali/dosing-and-administration)
